WAP
CANF

Wealthcare Advisory Partners’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Wealthcare Advisory Partners’s Portfolio CANF Stock Details CANF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed – – 742
2021
Q1 		$0 Buy
+1
New +$434 ﹤0.01% 2062

Other funds holding CANF

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Wealthcare Advisory Partners's CANF Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q2 2021, closing a stake of 1 share.

Wealthcare Advisory Partners first reported a position in CANF in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 11 funds tracked by Wall St. Rank hold CANF as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 1 Can-Fite BioPharma American Depositary Shares share in Q2 2021.
  • Wealthcare Advisory Partners first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Wealthcare Advisory Partners's Can-Fite BioPharma American Depositary Shares position peaked at $0 in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.